S&P ASX All Technology

3,774.20

1.78%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

IMNN Imunon Inc

0.913

0.0223 (2.50%)

Pre Market

Last Updated: 00:10:22

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Imunon (NASDAQ:IMNN)
Historical Stock Chart
From Feb 2025 to Mar 2025

Imunon (NASDAQ:IMNN)
Historical Stock Chart
From Mar 2024 to Mar 2025

Imunon Inc News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 28 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (4 days ago) • Edgar (US Regulatory)

IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
Friday 28 February 2025 (4 days ago) • GlobeNewswire Inc.

IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Thursday 27 February 2025 (5 days ago) • GlobeNewswire Inc.

IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025
Friday 21 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer
Thursday 20 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 February 2025 (3 weeks ago) • Edgar (US Regulatory)

IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer
Tuesday 11 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

IMNN Imunon Inc

Imunon Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

IMNN Imunon Inc

Imunon Inc News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free